Filed: 2/14/2023ACC: 0001398344-23-003145
π What this filing means
ESSEX WOODLANDS MANAGEMENT, INC. filed this quarterly 13FβHR report disclosing 7 equity positions with a total reported market value of $179.34M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
7
Positions
$179.34M
Total AUM (reported)
76.71M
Total Shares
Allocation by class
COM$130.83M73.0%
COM CL A$31.57M17.6%
COM NEW$16.94M9.4%
Portfolio Concentration
Top 3$143.94M80.3%
4β10$35.40M19.7%
Top 3 weight
80.3%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 76.71M
Sole
Full voting authority
76.71M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole7
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings7
Rows:
MIMEDX GROUP, INC.
SOLEShares23.42M
TypeSH
Market value$65.10M
36.30%
Sole
23.42M
Shared
0.00
None
0.00
TELA BIO, INC.
SOLEShares4.11M
TypeSH
Market value$47.27M
26.36%
Sole
4.11M
Shared
0.00
None
0.00
BIOVENTUS
SOLEShares12.10M
TypeSH
Market value$31.57M
17.60%
Sole
12.10M
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
SOLEShares4.19M
TypeSH
Market value$14.67M
8.18%
Sole
4.19M
Shared
0.00
None
0.00
VENUS CONCEPT, INC.
SOLEShares31.34M
TypeSH
Market value$10.03M
5.59%
Sole
31.34M
Shared
0.00
None
0.00
REVANCE THERAPEUTICS INC
SOLEShares457.08K
TypeSH
Market value$8.44M
4.70%
Sole
457.08K
Shared
0.00
None
0.00
MEDICINOVA INC
SOLEShares1.11M
TypeSH
Market value$2.27M
1.26%
Sole
1.11M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting β Sole | Shared | None |
|---|---|---|---|---|---|---|---|
MIMEDX GROUP, INC.SOLE | COM | 23.42M | SH | $65.10M 36.30% | 23.42M | 0.00 | 0.00 |
TELA BIO, INC.SOLE | COM | 4.11M | SH | $47.27M 26.36% | 4.11M | 0.00 | 0.00 |
BIOVENTUSSOLE | COM CL A | 12.10M | SH | $31.57M 17.60% | 12.10M | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCSOLE | COM NEW | 4.19M | SH | $14.67M 8.18% | 4.19M | 0.00 | 0.00 |
VENUS CONCEPT, INC.SOLE | COM | 31.34M | SH | $10.03M 5.59% | 31.34M | 0.00 | 0.00 |
REVANCE THERAPEUTICS INCSOLE | COM | 457.08K | SH | $8.44M 4.70% | 457.08K | 0.00 | 0.00 |
MEDICINOVA INCSOLE | COM NEW | 1.11M | SH | $2.27M 1.26% | 1.11M | 0.00 | 0.00 |